ARCHIVES

SWOG, NCI Canada halt two large trials of Iressa for non-small cell lung cancer.

This article is from The Cancer Letter archive.

Vol. 31 No. 16 | April 22, 2005

Download PDF Visit The Full Archive

Related Articles

Waxman Subcommittee Hears Support For Cancer Act Renewal

March 7, 1980

Conversation With The Cancer Letter: PanCAN CEO Denies Bill Would Undermine NCI’s Role in Directing and Funding Research

August 3, 2012

Letter to the Editors: Society of Toxicology Comments On President’s Cancer Panel Report

August 6, 2010

Caribbean Conference Reports Incidence Differences With U.S.

August 22, 1986

Signet Cell A Rising Trend In Patients Under Age 40

November 25, 2011

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009